The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells. US-based pharmaceutical major Pfizer’s Chief Executive Officer Albert Bourla said that the…
Covid-19 oral pill could be ready by year-end: Pfizer CEO
